# Predictors of the Response to Adalimumab in Rheumatoid Arthritis

> **NCT00234234** · PHASE4 · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 200 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT00234234
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2012-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234234, "Predictors of the Response to Adalimumab in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-09-16 from https://api.ai-analytics.org/clinical/NCT00234234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*